Augmedix Announces New Board Member, Jennifer M. Carter
Augmedix has announced that Jennifer M. Carter, Vice President, Venture Operations at McKesson Ventures, will join its board of directors.
At McKesson Ventures, Carter leads a team responsible for investing, fund management, portfolio development, marketing, and PR. She has more than 20 years of healthcare experience in roles across the McKesson enterprise ranging from strategy to Six Sigma.
“We’re looking forward to Jennifer joining the Augmedix board,” said Augmedix CEO Manny Krakaris. “Her expertise in healthcare, especially the strategic development of innovative organizations like Augmedix, will provide invaluable guidance as we continue to develop leading-edge solutions in telehealth and medical documentation.”
Carter replaces outgoing board member Tom Rodgers, who recently moved from his position as McKesson Ventures Senior Vice President and Managing Director to an Executive Vice President and Chief Strategy Officer role at McKesson Ventures’ parent company, McKesson Corporation.
McKesson Ventures is a strategic venture firm that focuses on early and growth-stage companies. Backed by McKesson Corporation, McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. healthcare landscape.
Read the full press release here.